The following companies are generously sponsoring the 2009 ASM. Click on their logo to visit their website.

Gold Sponsors

Silver Sponsors

Technology for Life

Dräger is an international leader in the fields of medical and safety technology. The family-owned company was founded in Lübeck, Germany, in 1889. Over the past five generations, Dräger has evolved into a publicly traded, worldwide group. The company’s long-term success is based on the four key strengths of its value-driven culture: customer intimacy, professional employees, continuous innovation and a commitment to outstanding quality.

“Technology for Life” is the guiding philosophy. Whether in clinical applications, industry, mining or fire and emergency services, Dräger products protect, support and save lives.

The current product range of the medical division includes anesthesia workstations, ventilators for emergency, critical and home care as well as warming therapy for premature infants. Patient monitoring, IT solutions, accessories and consumables, ceiling supply units, light systems and central supply systems for medical gases complete the portfolio.

Dräger has about 10,000 employees worldwide and is currently present in more than 190 countries. The company has sales and service subsidiaries in over 40 countries. Its development and production facilities are based in Germany, Great Britain, Sweden, the Netherlands, South Africa, the USA and China.

Mindray is a leading developer, manufacturer and marketer of medical devices. Established in 1991, Mindray offers a broad range of products across three primary business segments: patient monitoring & life support products, in-vitro diagnostic products and medical imaging systems, aiming to bring accessible and affordable medical equipment to customers worldwide. To date, Mindray products have entered more than 190 countries and regions.
Mindray is globally headquartered in Shenzhen, China. Research centers in Shenzhen, Beijing, Nanjing, Seattle and New Jersey collaborate together as an effective global research system. A sound distribution and service network has been formed with branch companies in 29 major cities of China and overseas subsidiaries in U.S., Canada, UK, Netherlands, Germany, France, Italy, Russia, Turkey, India, Mexico and Brazil. By Dec. 2008, over 5,500 employees work globally for Mindray.
With the acquisition of Datascope Corporation’s patient monitoring business in May 2008, Mindray became the third-largest player in the global patient monitoring device industry.
Our Company's American Depositary Shares (ADSs) are listed on the New York Stock Exchange (NYSE) under the symbol MR.

At Philips, we simplify healthcare by focusing on the people in the care cycle - patients and care providers. We’re committed to developing tools that deliver value throughout the complete cycle of care - from disease prevention to screening and diagnosis, to treatment, health management and monitoring - in key areas including cardiology, oncology, critical care and women’s health. By combining human insights and clinical expertise, we aim to develop innovative solutions that improve patient outcomes at lower overall costs.

Edwards Lifesciences is the global leader in the science of hemodynamic monitoring and heart valves. Edwards treats advanced cardiovascular disease with its market-leading critical care technologies,heart valve and vascular products. In 2008, Edwards celebrates 50 years of partnering with clinicians to develop life-saving innovations.
The company's global brands include, Swan-Ganz, FloTrac, Truwave, Carpentier-Edwards, Cosgrove-Edwards Fogarty and PERIMOUNT Magna.
Edwards Lifesciences leverages its research, design, development and marketing expertise to produce products that address specific clinical problems including critical care technologies, heart valve disease, and vascular disease.

The Acute Blood Purification division is a complementary product offer. The advanced design of the Aquarius System is intended to offer enhanced accuracy and convenience, offering a large spectrum of therapies with an ongoing commitment in product innovation. Still today the Aquarius System continues to elvolve.

Edwards Lifesciences constantly work to support our clinicians to fulfill important therapy goals.

Edwards Lifesciences Critical Care Technology products include:
Vigileo Arterial Pressure Cardiac Output Monitor
Swan Ganz ™ catheters, Monitoring, CCO/SVO2 /CEDV, Pacing catheters,
TruWave Pressure monitoring products,
Vigilance Continuous Cardiac Output computers,
AVA3xi and AVA High Flow - Advanced Venous Access catheters,
Multimed Central Venous catheters,
Vantex Oligon™ Antimicrobial Central Venous catheters,
Introflex Introducers
Acute Blood Purification – Aquarius Machine

Janssen-Cilag Australia is a leading, research-based, pharmaceutical company, dedicated to improving the health and well being of all Australians. Consistent with our Credo, our mission is to be the worldwide leader in providing quality healthcare products and services to patients. In achieving this we seek continued innovation across all divisions of the organization, with meeting the needs of patients being our primary focus and drive.

Janssen-Cilag is committed to clinical research in the areas of anti-infectives, oncology, virology, central nervous system, mental disorders, the gastro-intestinal system and renal failure. The result of this commitment has been the development of over 75 new drugs since our parent company’s inception. These include DORIBAX®, PREZISTA®, VELCADE®, RISPERDAL®, REMINYL®, TOPAMAX®, PARIET®, EPREX®, PROGRAF® and DUROGESIC®. This rate of discovery makes us one of the most innovative and cutting edge pharmaceutical companies in the world. This trend is set to continue as we move into new areas such as biotechnology and genomics, which represent the promise of entirely new and highly targeted therapies for a range of diseases.

Bronze sponsor

GE Healthcare provides transformational medical technologies and services that are shaping a new age of patient care. Our expertise in medical imaging, medical diagnostics, patient monitoring systems, performance improvement, drug discovery and biopharmaceutical manufacturing technologies is helping clinicians around the world re-imagine new ways to predict, diagnose, inform, treat and monitor disease, so patients can live their lives to the fullest.
GE Healthcare's broad range of products and services enable healthcare providers to better diagnose and treat cancer, heart disease, neurological diseases and other conditions earlier. Our vision for the future is to enable a new "Early Health" model of care focused on earlier diagnosis, pre-symptomatic disease detection and disease prevention. It’s Healthcare Re-imagined.
For more information visit www.gehealthcare.com

Breakfast session sponsors